GlassScriptPhysician profile
Ngoc-Bich P Le
NPI 1386712040
$11,196.22
in general payments reported to CMS, 2019-2025
13 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,865 · 2020: $1,445 · 2021: $1,398 · 2022: $432 · 2023: $2,205 · 2024: $606 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,022 · Travel and Lodging: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.98 |
| Travel and Lodging | $1,033.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,740.55 | 2019-2020 | |
| Medtronic, INC. | $2,020.78 | 2021-2025 | Interstim, Nuro, Vanta Adaptivestim |
| Valencia Technologies Corporation | $1,270.02 | 2023-2024 | Ecoin Device Kit |
| Axonics, INC. | $1,172.80 | 2021 | |
| Medtronic USA, INC. | $317.61 | 2019-2020 | |
| Allergan, INC. | $194.02 | 2019-2021 | |
| Abbvie INC. | $165.28 | 2023-2025 | |
| Astellas Pharma US INC | $161.30 | 2019-2024 | Veozah |
| 180 Medical, INC. | $95.31 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $23.31 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $13.62 | 2022 | |
| Dentsply Ih INC. | $13.60 | 2020 | |
| Dynavax Technologies Corporation | $8.02 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ngoc-Bich Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.